CLNN — Clene Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1822791 ·
Last close
$4.06
Market Cap
$52.16M
52W High
$13.50
52W Low
$3.25
ADV30
119,767
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 90,000 | 54,000 | -5,164,000 | -13,424,000 | 23,041,000 | 9,671,000 | 47,818,000 |
| Mar 2026 | 15,000 | 15,000 | -1,692,000 | -8,091,000 | 21,665,000 | 5,939,000 | 40,471,000 |
| Dec 2025 | 77,000 | 54,000 | -7,244,000 | -9,226,000 | 18,131,000 | 5,189,000 | 35,723,000 |
| Sep 2025 | 15,000 | 15,000 | -5,373,000 | -8,777,000 | 22,311,000 | 7,925,000 | 34,668,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-18,063,000
Investing CF
$-39,000
Financing CF
$14,079,000
CapEx
$-29,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.41
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-316,387,000
Inventory
$54,000
Receivables
$3,512,000
ST Investments
$0
EBIT TTM
$-30,648,000
Pretax Income TTM
$-33,513,000
Interest Exp TTM
$2,865,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$197,000
EBITDA
$-19,118,000
Free Cash Flow
$-9,874,000
Enterprise Value
$58,542,192
Total Cash
$9,671,000
Total Debt
$22,344,000
Shares Out
12,848,513
Trailing EPS
$-3.55
Book Value
$-1.94
ROE
—
ROA
-56.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 200,000 | -21,816,000 | -26,173,000 | 18,131,000 | 35,723,000 | -17,592,000 | -18,546,000 |
| Dec 2024 | 342,000 | -31,975,000 | -39,400,000 | 27,337,000 | 36,194,000 | -8,857,000 | -21,326,000 |
| Dec 2023 | 654,000 | -38,260,000 | -49,504,000 | 52,341,000 | 38,951,000 | 13,390,000 | -30,171,000 |
| Dec 2022 | 473,000 | -44,557,000 | -29,918,000 | 44,493,000 | 41,256,000 | 3,237,000 | -39,011,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.44
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $4.06 · call volume: 0 · put volume: 152Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SER | Serina Therapeutics, Inc. | $51.05M | $2.01 | — |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | $55.40M | $0.29 | — |
| ELTX | Elicio Therapeutics, Inc. | $48.62M | $1.85 | — |
| ANVS | Annovis Bio, Inc. | $58.80M | $1.38 | — |
| LITS | Lite Strategy, Inc. | $46.27M | $1.36 | — |
News headlines (Yahoo Finance, 1h cache)
Clene to Present at Upcoming Investor Conferences
2026-09-22 12:00 · Yahoo
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
2026-09-21 12:30 · Yahoo
Clene Announces $4 Million Registered Direct Offering
2026-09-15 13:00 · Yahoo
Clene to Present at Upcoming September Investor Conferences
2026-09-03 12:00 · Yahoo
Clene Eyes Q4 NDA for ALS Drug After FDA-Requested Biomarker Analyses
2026-08-19 22:03 · Yahoo
Clene to Present at the Emerging Growth Conference
2026-08-17 12:30 · Yahoo
Clene Inc. (CLNN) Reports Q2 Loss, Beats Revenue Estimates
2026-08-14 13:20 · Yahoo
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
2026-08-14 12:30 · Yahoo
Clene Targets Early Q4 NDA Filing for CNM-Au8 in ALS
2026-08-12 10:02 · Yahoo
Clene (CLNN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
2026-06-04 13:55 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.